Skip to content

Safety and efficacy of Sakriyam Pain Oil for the patients with Muscular pain.

An Open Label, Single Arm Clinical Study to Evaluate the safety and efficacy of Sakriyam Pain Oil for the patients with Muscular pain. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/091805
Enrollment
36
Registered
2025-07-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L989- Disorder of the skin and subcutaneous tissue, unspecified

Interventions

Intervention1: Test Product: Sakriyam Pain Oil: Dose: Apply oil two times a day Route of Administration: Topical Duration: 30 Days Control Intervention1: Not Applicable: Not Applicable

Sponsors

Jeena Sikho Lifecare Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects having Muscular pain. 2. Subjects from 18 to 65 years of age. 3. If female with childbearing potential, must be willing to practice an acceptable form of birth control for the duration of the study. 4. Subjects that are able to give written informed consent in a manner approved by the institutional ethics committee and comply with the requirements of the study. 5. Subjects willing to avoid participation in any other interventional clinical trial for the duration of the study.

Exclusion criteria

Exclusion criteria: 1. Subjects that are pregnant, breast feeding, or planning to get pregnant during the study. 2. Subjects that have participated in any other interventional clinical trial in the previous 30 days. 3. Subjects with known sensitivity to any of the constituents of the investigational product

Design outcomes

Primary

MeasureTime frame
1. Change in SGA score 2. Change in WOMAC score 3. Change in Musculoskeletal Health score Timepoint: Time Frame Day1, Day15 and Day30

Secondary

MeasureTime frame
1. Change in VAS score 2. Change in EQ-5D-5L Score Timepoint: Time Frame Day 1, Day 30

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org08937015757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026